Biophysical characteristics of proteins and living cells exposed to the green tea polyphenol epigallocatechin-3-gallate (EGCg): review of recent advances from molecular mechanisms to nanomedicine and clinical trials

European Biophysics Journal

Volumn 46, Issue 1, 2017, Pages

  Peter, Beatrix ^a,b   Bosze, Szilvia ^c   Horvath, Robert ^b  

^a UNIVERSITY OF PANNONIA   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c EÖTVÖS LORÁND UNIVERSITY   (Hungary)

Author keywords

Anticancer effects; Cell adhesion; EGCg; Nanoparticles; Polyphenol; Proteins

Indexed keywords

EPIGALLOCATECHIN GALLATE; LAMININ; LAMININ RECEPTOR; LIPOSOME; NANOPARTICLE; NATURAL PRODUCT; CATECHIN; PROTEIN; TEA;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; BIOAVAILABILITY; BIOSENSOR; CANCER CELL; CELL ADHESION; CELL MIGRATION; CELL MOTILITY; CELL PROLIFERATION; CHINESE MEDICINE; CLINICAL TRIAL (TOPIC); HUMAN; HUMAN CELL CULTURE; IN VITRO STUDY; MICELLE; NONHUMAN; PRIORITY JOURNAL; PROTEIN MISFOLDING; REVIEW; RIGIDITY; SIGNAL TRANSDUCTION; TEA; ANALOGS AND DERIVATIVES; ANIMAL; BIOPHYSICS; CELLS; CHEMISTRY; CYTOLOGY; DRUG EFFECTS; METABOLISM; NANOMEDICINE; PROCEDURES;

ANIMALS; BIOPHYSICAL PHENOMENA; CATECHIN; CELLS; CLINICAL TRIALS AS TOPIC; HUMANS; NANOMEDICINE; PROTEINS; TEA;

EID: 84975159084     PISSN: 01757571     EISSN: 14321017     Source Type: Journal    
DOI: 10.1007/s00249-016-1141-2     Document Type: Review

References (93)

1. Ahmad N, Gupta S, Mukhtar H (2000) Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells. Arch Biochem Biophys 376:338–346. doi:10.1006/abbi.2000.1742 (and the references therein)
2. Anand PK, Kaul D, Sharma M (2006) Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. Int J Biochem Cell Biol 38:600–609. doi:10.1016/j.biocel.2005.10.021 (and the references therein)
3. Byun EH, Omura T, Yamada K, Tachibana H (2011) Green tea polyphenol epigallocatechin-3-gallate inhibits TLR2 signaling induced by peptidoglycan through the polyphenol sensing molecule 67-kDa laminin receptor. FEBS Lett 585:814–820. doi:10.1016/j.febslet.2011.02.010 (and the references therein)
4. Chan C-M, Huang J-H, Chiang H-S et al (2010) Effects of (−)-epigallocatechin gallate on RPE cell migration and adhesion. Mol Vis 16:586–595
5. Chandrashekaran IR, Adda CG, Macraild CA et al (2012) EGCG disaggregates amyloid-like fibrils formed by Plasmodium falciparum merozoite surface protein 2. NIH Public Access 513:153–157. doi:10.1016/j.abb.2011.07.008.EGCG (and the references therein)
6. Chung JE, Tan S, Gao SJ et al (2014) Self-assembled micellar nanocomplexes comprising green tea catechin derivatives and protein drugs for cancer therapy. Nat Nanotechnol 9:907–912. doi:10.1038/nnano.2014.208
7. D’Agostino EM, Rossetti D, Atkins D et al (2012) Interaction of tea polyphenols and food constituents with model gut epithelia: the protective role of the mucus gel layer. J Agric Food Chem 60:3318–3328. doi:10.1021/jf205111k
8. Das S, Tanwar J, Hameed S et al (2014) Antimicrobial potential of epigallocatechin-3-gallate (EGCG): a green tea polyphenol. J Biochem Pharmacol Res 2:167–174 (and the references therein)
9. Davies HS, Pudney PD, Georgiades P et al (2014) Reorganisation of the salivary mucin network by dietary components: insights from green tea polyphenols. PLoS One 9:e108372. doi:10.1371/journal.pone.0108372 (and the references therein)
10. Davison CA, Durbin SM, Thau MR et al (2013) Antioxidant enzymes mediate survival of breast cancer cells deprived of extracellular matrix. Cancer Res 73:3704–3715. doi:10.1158/0008-5472.CAN-12-2482
11. de Pace RCC, Liu X, Sun M et al (2013) Anticancer activities of (−)-epigallocatechin-3-gallate encapsulated nanoliposomes in MCF7 breast cancer cells. J Liposome Res 23:187–196. doi:10.3109/08982104.2013.788023
12. Ding J, Kong X, Yao J et al (2012) Core–shell mesoporous silica nanoparticles improve HeLa cell growth and proliferation inhibition by (−)-epigallocatechin-3-gallate by prolonging the half-life. J Mater Chem 22:19926. doi:10.1039/c2jm32271d
13. Dube A, Nicolazzo JA, Larson I (2010) Chitosan nanoparticles enhance the intestinal absorption of the green tea catechins (+)-catechin and (−)-epigallocatechin gallate. Eur J Pharm Sci 41:219–225. doi:10.1016/j.ejps.2010.06.010
14. Dufresne CJ, Farnworth ER (2001) A review of latest research findings on the health promotion properties of tea. J Nutr Biochem 12:404–421. doi:10.1016/S0955-2863(01)00155-3 (and the references therein)
15. El-Schish Z, Mölder A, Sebesta M et al (2010) Digital holographic microscopy—innovative and non-destructive analysis of living cells. In: Microscopy: science, technology, applications and education, pp 1055–1062
16. Fatima Z, Hameed S, Islam N (2012) expression of Mycobacterium tuberculosis 85B and proinflammatory TNF-α in human monocytes. Int J Sci Pub 2:1–6
17. Fujiki H, Sueoka E, Watanabe T, Suganuma M (2014) Synergistic enhancement of anticancer effects on numerous human cancer cell lines treated with the combination of EGCG, other green tea catechins, and anticancer compounds. J Cancer Res Clin Oncol 141:1511–1522. doi:10.1007/s00432-014-1899-5 (and the references therein)
18. Fujimura Y, Umeda D, Yano S et al (2007) The 67 kDa laminin receptor as a primary determinant of anti-allergic effects of O-methylated EGCG. Biochem Biophys Res Commun 364:79–85. doi:10.1016/j.bbrc.2007.09.095
19. Fujimura Y, Umeda D, Yamada K, Tachibana H (2008) The impact of the 67 kDa laminin receptor on both cell-surface binding and anti-allergic action of tea catechins. Arch Biochem Biophys 476:133–138. doi:10.1016/j.abb.2008.03.002 (and the references therein)
20. Fujimura Y, Sumida M, Sugihara K et al (2012) Green tea polyphenol EGCG sensing motif on the 67-kDa laminin receptor. PLoS One. doi:10.1371/journal.pone.0037942
21. Georgiades P, Pudney PD, Rogers S et al (2014) Tea derived galloylated polyphenols cross-link purified gastrointestinal mucins. PLoS One 9:e105302. doi:10.1371/journal.pone.0105302
22. Gu J, Makey KL, Tucker KB et al (2013) EGCG, a major green tea catechin suppresses breast tumor angiogenesis and growth via inhibiting the activation of HIF-1α and NFκB, and VEGF expression. Vasc Cell 5:1–10. doi:10.1186/2045-824X-5-9
23. Haratifar S, Meckling KA, Corredig M (2014) Antiproliferative activity of tea catechins associated with casein micelles, using HT29 colon cancer cells. J Dairy Sci 97:672–678. doi:10.3168/jds.2013-7263
24. Hayakawa S, Saeki K, Sazuka M et al (2001) Apoptosis induction by epigallocatechin gallate involves its binding to Fas. Biochem Biophys Res Commun 285:1102–1106. doi:10.1006/bbrc.2001.5293
25. Hellmann JK, Münter S, Wink M, Frischknecht F (2010) Synergistic and additive effects of epigallocatechin gallate and digitonin on Plasmodium sporozoite survival and motility. PLoS One 5:1–7. doi:10.1371/journal.pone.0008682
26. Hirun S, Roach PD (2011) A study of stability of (−)-epigallocatechin gallate (EGCG) from green tea in a frozen product. Int Food Res J 18:1261–1264
27. Hong J, Lu H, Meng X et al (2002) Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells stability, cellular uptake, biotransformation, and efflux of tea polyphenol. Cancer Res 62:7241–7246 (and the references therein)
28. Horvath R, McColl J, Yakubov GE, Ramsden JJ (2008) Structural hysteresis and hierarchy in adsorbed glycoproteins. J Chem Phys 129:1–5. doi:10.1063/1.2968127
29. Hou Z, Sang S, You H et al (2005) Mechanism of action of (−)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res 65:8049–8056. doi:10.1158/0008-5472.CAN-05-0480 (and the references therein)
30. Hu B, Ting Y, Yang X et al (2012) Nanochemoprevention by encapsulation of (−)-epigallocatechin-3-gallate with bioactive peptides/chitosan nanoparticles for enhancement of its bioavailability. Chem Commun 48:2421. doi:10.1039/c2cc17295j
31. Hu F, Wei F, Wang Y et al (2015) EGCG synergizes the therapeutic effect of cisplatin and oxaliplatin through autophagic pathway in human colorectal cancer cells. J Pharmacol Sci 128:27–34. doi:10.1016/j.jphs.2015.04.003
32. Hudson SA, Ecroyd H, Dehle FC et al (2009) (−)-Epigallocatechin-3-gallate (EGCG) maintains κ-casein in its pre-fibrillar state without redirecting its aggregation pathway. J Mol Biol 392:689–700. doi:10.1016/j.jmb.2009.07.031
33. Ishii T, Ichikawa T, Minoda K et al (2011) Human serum albumin as an antioxidant in the oxidation of (−)-epigallocatechin gallate: participation of reversible covalent binding for interaction and stabilization. Biosci Biotechnol Biochem 75:100–106. doi:10.1271/bbb.100600
34. Khalfaoui T, Groulx J-F, Sabra G et al (2013) Laminin receptor 37/67LR regulates adhesion and proliferation of normal human intestinal epithelial cells. PLoS One 8:e74337. doi:10.1371/journal.pone.0074337
35. Kim S, Lee MJ, Hong J et al (2000) Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr Cancer 37:41–48. doi:10.1207/S15327914NC3701_5 (and the references therein)
36. Kim HS, Quon MJ, Kim JA (2014) New insights into the mechanisms of polyphenols beyond antioxidant properties; lessons from the green tea polyphenol, epigallocatechin 3-gallate. Redox Biol 2:187–195. doi:10.1016/j.redox.2013.12.022 (and the references therein)
37. Kiss A, Bécsi B, Kolozsvári B et al (2013) Epigallocatechin-3-gallate and penta-O-galloyl-β-d-glucose inhibit protein phosphatase-1. FEBS J 280:612–626. doi:10.1111/j.1742-4658.2012.08498.x
38. Klein EA, Thompson IM Jr, Tangen CM et al (2011) Vitamin E and the risk of prostate cancer: the selenium and vitamin E cancer prevention trial (SELECT). JAMA 306:1549–1556
39. Koehn FE, Carter GT (2005) The evolving role of natural products in drug discovery. Nat Rev Drug Discov 4:206–220. doi:10.1038/nrd1657 (and the references therein)
40. Lambert JD, Lee M-J, Diamond L et al (2006) Dose dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab Dispos 34:8–11. doi:10.1124/dmd.104.003434
41. Landis-Piwowar K, Chen D, Foldes R et al (2013) Novel epigallocatechin gallate analogs as potential anticancer agents: a patent review (2009–present). Expert Opin Ther Pat 23:189–202. doi:10.1517/13543776.2013.743993 (and the references therein)
42. Li W, Zhu S, Li J et al (2011) EGCG stimulates autophagy and reduces cytoplasmic HMGB1 levels in endotoxin-stimulated macrophages. Biochem Pharmacol 81:1152–1163. doi:10.1016/j.bcp.2011.02.015
43. Liang X, Wang J, Zhang X, Fang Y (2015) Label-free cell phenotypic identification of active compounds in traditional Chinese medicines. In: Fang Y (ed) Label-free biosensor methods in drug discovery. Springer, New York, pp 233–252
44. Lo HM, Hung CF, Huang YY, Bin WuW (2007) Tea polyphenols inhibit rat vascular smooth muscle cell adhesion and migration on collagen and laminin via interference with cell–ECM interaction. J Biomed Sci 14:637–645. doi:10.1007/s11373-007-9170-6
45. Lu LY, Ou N, Lu Q-B (2013) Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells. Sci Rep 3:3169. doi:10.1038/srep03169
46. Lu Y-C, Luo P-C, Huang C-W et al (2014) Augmented cellular uptake of nanoparticles using tea catechins: effect of surface modification on nanoparticle–cell interaction. Nanoscale 6:10297–10306. doi:10.1039/c4nr00617h
47. Luo X, Guan R, Chen X et al (2014) Optimization on condition of epigallocatechin-3-gallate (EGCG) nanoliposomes by response surface methodology and cellular uptake studies in Caco-2 cells. Nanoscale Res Lett 9:291. doi:10.1186/1556-276X-9-291 (and the references therein)
48. Mandel SA, Amit T, Weinreb O et al (2008) Simultaneous manipulation of multiple brain targets by green tea catechins: a potential neuroprotective strategy for Alzheimer and Parkinson diseases. CNS Neurosci Ther 14:352–365. doi:10.1111/j.1755-5949.2008.00060.x
49. McColl J, Horvath R, Aref A et al (2009) Polyphenol control of cell spreading on glycoprotein substrata. J Biomater Sci Polym Ed 20:841–851. doi:10.1163/156856209X427023
50. McColl J, Horvath R, Yakubov GE, Ramsden JJ (2016) The adsorption of EGCG–mucin complexes on biomimetic surfaces. 1–18 (to appear)
51. Melgarejo E, Medina MÁ, Sánchez-Jiménez F, Urdiales JL (2009) Epigallocatechin gallate reduces human monocyte mobility and adhesion in vitro. Br J Pharmacol 158:1705–1712. doi:10.1111/j.1476-5381.2009.00452.x
52. Mereles D, Hunstein W (2011) Epigallocatechin-3-gallate (EGCG) for clinical trials: more pitfalls than promises? Int J Mol Sci 12:5592–5603. doi:10.3390/ijms12095592 (and the references therein)
53. Mizooku Y, Yoshikawa M, Tsuneyoshi T, Arakawa R (2003) Analysis of oxidized epigallocatechin gallate by liquid chromatography/mass spectrometry. Rapid Commun Mass Spectrom 17:1915–1918. doi:10.1002/rcm.1135
54. Mukhtar H, Ahmad N (2000) Tea polyphenols: prevention of cancer and optimizing health. Am J Clin Nutr 71:1698–1702 (and the references therein)
55. Nelson J, McFerran NV, Pivato G et al (2008) The 67 kDa laminin receptor: structure, function and role in disease. Biosci Rep 28:33–48. doi:10.1042/BSR20070004 (and the references therein)
56. Omenn GS, Goodman GE, Thornquist MD et al (1996) Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 334:1150–1155. doi:10.1056/NEJM199605023341802
57. Orgovan N, Peter B, Bősze S et al (2014) Dependence of cancer cell adhesion kinetics on integrin ligand surface density measured by a high-throughput label-free resonant waveguide grating biosensor. Sci Rep 4:4034
58. Patil PR, Gemma S, Campiani G, Craig AG (2011) Broad inhibition of plasmodium falciparum cytoadherence by (+)-epigallocatechin gallate. Malar J 10:348. doi:10.1186/1475-2875-10-348
59. Patra SK, Rizzi F, Silva A et al (2014) Molecular targets of (−)-epigallocatechin-3-gallate (EGCG): specificity and interaction with membrane lipid rafts. J Physiol Pharmacol 59:217–235. doi:10.1056/NEJMra1313875 (and the references therein)
60. Persson J, Mölder A, Pettersson S, Alm K (2010) Cell motility studies using digital holographic microscopy. In: Méndez-Vilas A, Díaz J (eds) Microscopy: science, technology, applications and education. Formatex, Badajoz, pp 1063–1072
61. Peter B, Nador J, Juhasz K et al (2015) Incubator proof miniaturized Holomonitor to in situ monitor cancer cells exposed to green tea polyphenol and preosteoblast cells adhering on nanostructured titanate surfaces: validity of the measured parameters and their corrections. J Biomed Opt 20:067002. doi:10.1117/1.JBO.20.6.067002
62. Punathil T, Tollefsbol TO, Katiyar SK (2008) EGCG inhibits mammary cancer cell migration through inhibition of nitric oxide synthase and guanylate cyclase. Biochem Biophys Res Commun 375:162–167. doi:10.1016/j.bbrc.2008.07.157
63. Sazuka M, Itoi T, Suzuki Y et al (1996) Evidence for the interaction between (−)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein. Biosci Biotechnol Biochem 60:1317–1319
64. Scarpa E-S, Ninfali P (2015) Phytochemicals as innovative therapeutic tools against cancer stem cells. Int J Mol Sci 16:15727–15742. doi:10.3390/ijms160715727 (and the references therein)
65. Sharma SK, Kumar G, Kapoor M, Surolia A (2008) Combined effect of epigallocatechin gallate and triclosan on enoyl-ACP reductase of Mycobacterium tuberculosis. Biochem Biophys Res Commun 368:12–17. doi:10.1016/j.bbrc.2007.10.191 (and the references therein)
66. 198AuNP-EGCg) show efficacy in treating prostate cancer. Proc Natl Acad Sci 109:12426–12431. doi:10.1073/pnas.1121174109
67. Siddiqui IA, Asim M, Hafeez BB et al (2011) Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer. FASEB J 25:1198–1207. doi:10.1096/fj.10-167924
68. Singh BN, Shankar S, Srivastava RK (2011) Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications. Biochem Pharmacol 82:1807–1821. doi:10.1016/j.bcp.2011.07.093 (and the references therein)
69. Song Q, Li D, Zhou Y et al (2014a) Enhanced uptake and transport of (+)-catechin and (−)-epigallocatechin gallate in niosomal formulation by human intestinal Caco-2 cells. Int J Nanomed 9:2157–2165
70. Song S, Huang Y-W, Tian Y et al (2014b) Mechanism of action of (–)-epigallocatechin-3-gallate: auto-oxidation-dependent activation of extracellular signal-regulated kinase 1/2 in Jurkat cells. Chin J Nat Med 12:654–662. doi:10.1016/S1875-5364(14)60100-X
71. Sugisawa A, Umegaki K (2002) Physiological concentrations of (−)-epigallocatechin-3-O-gallate (EGCg) prevent chromosomal damage induced by reactive oxygen species in WIL2-NS cells. J Nutr 132:1836–1839
72. Suzuki Y, Isemura M (2001) Inhibitory effect of epigallocatechin gallate on adhesion of murine melanoma cells to laminin. Cancer Lett 173:15–20. doi:10.1016/S0304-3835(01)00685-1
73. Suzuki Y, Isemura M (2013) Binding interaction between (−)-epigallocatechin gallate causes impaired spreading of cancer cells on fibrinogen. Biomed Res 34:301–308. doi:10.2220/biomedres.34.301 (and the references therein)
74. Tachibana H (2011) Green tea polyphenol sensing. Proc Jpn Acad Ser B 87:66–80. doi:10.2183/pjab.87.66 (and the references therein)
75. Tachibana H, Koga K, Fujimura Y, Yamada K (2004) A receptor for green tea polyphenol EGCG. Nat Struct Mol Biol 11:380–381. doi:10.1038/nsmb743
76. Takahashi A, Watanabe T, Mondal A et al (2014) Mechanism-based inhibition of cancer metastasis with (−)-epigallocatechin gallate. Biochem Biophys Res Commun 443:1–6. doi:10.1016/j.bbrc.2013.10.094
77. Tao L, Park J-Y, Lambert JD (2015) Differential prooxidative effects of the green tea polyphenol, (−)-epigallocatechin-3-gallate, in normal and oral cancer cells are related to differences in sirtuin 3 signaling. Mol Nutr Food Res 59:203–211. doi:10.1002/mnfr.201400485
78. Tran PLCHB, Kim S-A, Choi HS et al (2010) Epigallocatechin-3-gallate suppresses the expression of HSP70 and HSP90 and exhibits anti-tumor activity in vitro and in vivo. BMC Cancer 10:276. doi:10.1186/1471-2407-10-276
79. Tudoran O, Soritau O, Balacescu O et al (2012) Early transcriptional pattern of angiogenesis induced by EGCG treatment in cervical tumour cells. J Cell Mol Med 16:520–530. doi:10.1111/j.1582-4934.2011.01346.x
80. Umeda D, Yano S, Yamada K, Tachibana H (2008a) Involvement of 67-kDa laminin receptor-mediated myosin phosphatase activation in antiproliferative effect of epigallocatechin-3-O-gallate at a physiological concentration on Caco-2 colon cancer cells. Biochem Biophys Res Commun 371:172–176. doi:10.1016/j.bbrc.2008.04.041
81. Umeda D, Yano S, Yamada K, Tachibana H (2008b) Green tea polyphenol epigallocatechin-3-gallate signaling pathway through 67-kDa laminin receptor. J Biol Chem 283:3050–3058. doi:10.1074/jbc.M707892200 (and the references therein)
82. Vaidyanathan JB, Walle T (2003) Cellular uptake and efflux of the tea flavonoid (−)epicatechin-3-gallate in the human intestinal cell line Caco-2. J Pharmacol Exp Ther 307:745–752. doi:10.1124/jpet.103.054296.genesis (and the references therein)
83. Wang P, Henning SM, Heber D (2010) Limitations of MTT and MTS-based assays for measurement of antiproliferative activity of green tea polyphenols. PLoS One. doi:10.1371/journal.pone.0010202
84. Wang S, Su R, Nie S et al (2014) Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals. J Nutr Biochem 25:363–376. doi:10.1016/j.jnutbio.2013.10.002 (and the references therein)
85. Weber AA, Neuhaus T, Skach RA et al (2004) Mechanisms of the inhibitory effects of epigallocatechin-3 gallate on platelet-derived growth factor-BB-induced cell signaling and mitogenesis. FASEB J 18:128–130. doi:10.1096/fj.03-0007fje (and the references therein)
86. Yang CS, Chen L, Lee M-J et al (1998) Blood and urine levels of tea catechins after ingestion of different amounts of green tea by human volunteers. Cancer Epidemiol Biomark 7:351–354
87. Yang CS, Wang X, Lu G, Picinich SC (2009) Cancer prevention by tea: animal studies, molecular mechanisms and human relevance. Nat Rev Cancer 9:429–439. doi:10.1038/nrc2641 (and the references therein)
88. Zhang Q, Tang X, Lu Q et al (2006) Green tea extract and (−)-epigallocatechin-3-gallate inhibit hypoxia- and serum-induced HIF-1alpha protein accumulation and VEGF expression in human cervical carcinoma and hepatoma cells. Mol Cancer Ther 5:1227–1238. doi:10.1158/1535-7163.MCT-05-0490
89. Zhang X, Deng H, Xiao Y et al (2014) Label-free cell phenotypic profiling identifies pharmacologically active compounds in two traditional Chinese medical plants. RSC Adv 4:26368. doi:10.1039/c4ra03609c
90. Zhao Y, Chen L, Yakubov G et al (2012) Experimental and theoretical studies on the binding of epigallocatechin gallate to purified porcine gastric mucin. J Phys Chem B 116:13010–13016
91. Zhao Y, Chen L, Han L et al (2013) Molecular and thermodynamic basis for EGCG–keratin interaction-part II: experimental investigation. AIChE J 59:4824–4827. doi:10.1002/aic.14221
92. Zheng FJ, Shi L, Yang J et al (2012) Effect of tea polyphenols on the adhesion of highly metastatic human lung carcinoma cell lines to endothelial cells in vitro. Asian Pac J Cancer Prev 13:3751–3755. doi:10.7314/APJCP.2012.13.8.3751
93. Zhou Q, Chiang H, Portocarrero C et al (2003) Investigating the stability of EGCg in aqueous media. Curr Sep 20:83–86